BIF – Quarterly Client Update

BIF – Quarterly Client Update – 30 June 2022
14 July 2022
Booster Investment Management Limited as Manager of the Fund (the Manager), has provided a copy of
the Quarterly Client Update for the quarter ended 30 June 2022.
For further information regarding the Booster Innovation Fund visit
www.booster.co.nz/booster-
investments/booster-innovation-fund

For more information, please contact:
Gary Scott
Company Secretary
Booster Investment Management Limited
04 8944300
About Booster
Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of
the Booster Group which has been helping New Zealanders save since 1998. The group currently
administers superannuation and investment funds of over $5 billion on behalf of more than 170,000 New
Zealanders.
BIF is a managed investment fund that invests in early-stage companies founded on intellectual property
originated or developed in New Zealand.
For more information, including a copy of the Product Disclosure Statement and the net asset value per
unit, please visit
www.booster.co.nz

Booster Innovation Scheme
Booster Innovation Fund

Update as at and for the quarter ending 30 June 2022


1
v
Portfolio Performance
The Booster Innovation Fund (BIF) has had a positive quarter ending 30
June 2022, returning 6.0% to June 2022 and 30% since inception (24
August 2021) (after fees and before tax). There have been valuation
movements in several of the companies invested in, with the majority of
these experiencing uplifts in response to their business and investment
activities and one adjusted downwards to reflect slower than expected
progress.
As at the end of June, the Booster Innovation Fund has equity related
assets and cash of $9.5m.
Portfolio Spotlight
The Fund is indirectly invested via the NZ Innovation Booster LP in
Alimetry Ltd, a medical device and digital healthcare company who is
pioneering non-invasive medical devices for aiding the diagnosis of
gastric disorders.
Alimetry recently announced it received US Food and Drug
Administration (FDA) clearance for its leading product, Gastric Alimetry.
This medical device harnesses the power of stretchable electronics,
wearables, digital health and cloud-based analytics to deliver a
completely non-invasive solution. The device is now approved for use in
NZ, US and UK to assess common stomach disorders including nausea
and vomiting, gastroparesis and functional dyspepsia which effects over
8% of the world’s population.

Portfolio Additions
During the quarter, BIF invested $1.5m and secured interests in four new
assets, Advemto Ltd, Orbis Diagnostics Ltd, Hot Lime Labs Ltd and ZeroJet
Ltd. Advemto (held via NZ Innovation Booster) sell ultrafast spectroscopy
systems which originated from research at Victoria University of
Wellington. The system enables scientists to reduce the time it takes to
conduct research from months down to just days. Orbis Diagnostics,
based on research from Auckland University, are developing point of
care diagnostics for use in pharmacy and other settings to measure a
person’s antibody concentration as a result of vaccination. Hot Lime Labs
develop carbon capture systems that convert wood biomass into clean
CO2 for commercial greenhouses to increase crop productivity and
growth. ZeroJet sell electric jet propulsion systems to eliminate the need
for combustion engines on small watercraft.
Key Facts

Risk Level
Early stage company investing is generally considered the riskiest type of
equity investing. While the fund is not required to calculate a Risk
Indicator based on the volatility of the fund (being the extent to which
the fund’s assets go up and down), we consider the fund’s risk rating
would equate to 7 on a scale of 1 (low) to 7 (high). Please see the Product
Disclosure Statement for a description of the circumstances that the
manager is aware of that exist or are likely to arise that significantly
increase the risk to returns for investors in the Booster Innovation Fund.


Performance as at 30 June 2022
1
BIF was recently created in August 2021. Potential returns on early stage
businesses are uncertain, difficult to predict and can range widely both
positively and negatively. By taking a portfolio approach to investing, the
Booster Innovation Fund aims to deliver a significant total rate of return
over rolling 15-year periods. Past performance is not an indicator of
future performance.
All figures are after fees. Please see the Product Disclosure Statement
for further details.
After tax return is higher than before tax due to tax credits from
performance based fees.
1
Past performance is not an indicator of future performance.






Fund Size
(net asset value)
$9.5 million
Inception Date 24/08/2021
Manager Booster Investment Management Limited
Supervisor Public Trust
Fund Type Portfolio Investment Entity (PIE)
Before Tax
After Tax at
28%
Last 3 months 6.0% 6.4%
Last 6 months 12.2% 12.9%
Since Inception 24/8/21 (p.a.) 30.3% 32.3%

Booster Innovation Scheme
Booster Innovation Fund

Update as at and for the quarter ending 30 June 2022


The Booster Innovation Fund (fund) is part of the Booster Innovation Scheme which is issued and managed by Booster Investment Management Ltd (Booster). The fund’s Product Disclosure
Statement is available at www.booster.co.nz, by contacting your financial adviser or by calling Booster on 0800 40 40 50.

Disclaimer: This document is for information purposes only. The information is derived from sources believed to be accurate as at the date of issue and may change. The content is of a general
nature and does not take into account your financial situation or goals and is not financial advice. Booster, its related companies, directors, board members and nominees do not accept any
liability for any loss or damage arising directly or indirectly out of the use of, or reliance on, the information provided in this document, nor do they guarantee the fund’s performance, returns
or repayment of capital.
2

v
BIF Investment Holdings
BIF holds interests in a portfolio of 23 investments with a total value of
$9.5m, across a range of business sectors as follows. We intend to
grow a more diversified portfolio, indicatively more than 40.
Part of the fund’s investments are held by investing in NZ Innovation
Booster LP (NZIB). For further information of how we invest through
NZIB refer to the Product Disclosure Statement on the booster.co.nz
website.
Description of Individual Holdings
Advemto Ltd Sell ultrafast spectroscopy systems, that can
reduce research analysis from months to days.
Alimetry Ltd Developing devices for aiding informed diagnostics
for gastric disease.
Allegro Energy Pty Ltd High performance water-based electrolytes
provide a low cost, clean and green energy storage
solution
Amaroq Therapeutics
Ltd
Developing a new class of therapeutics that target
long non-coding RNA in cancer.
Avalia
Immunotherapies Ltd
Developing vaccines that have the potential to
treat chronic hepatitis B and cancers.
Chitogel Ltd Providing sinus dressings that helps to enhance
wound healing and improve patient outcomes
post-surgery.
BioLumic Inc Improves crop yield and quality by treating seeds
and seedlings with UV-light recipes.
Codify Assets
Solutions (CAS) Ltd
Developing software that automates compliance,
management, and auditing of infrastructure assets.
Ferronova Pty Ltd Developing surgical tracer systems that are
designed to more accurately map cancer spread to
lymph nodes.
Inhibit Coatings Ltd Developing coatings to inhibit microbial
contamination and outbreaks in facilities with high
hygiene requirements.
InsituGen Ltd Developing testing solutions for the detection of
performance enhancing drug use in animals and
humans.
Hot Lime Labs Ltd Developing carbon capture systems to convert
wood biomass into clean CO2 for use in
horticulture.
Jaipuna Ltd
(trading as Amy.app)
Providing an online private tutor for maths that
makes learning maths easy for everyone.
Ligar Ltd Partnership Developing solutions for highly-selective capture
and extraction of molecules for use in medicine,
flavours or nutraceuticals.
Marama Labs Ltd Providing meaningful data to help wineries
improve the quality of their wine production.
Mekonos Inc Developing silicon chips, with hundreds of moving
nano-needles, to help improve drug development
and drug delivery to patients.
Montoux Ltd Actuarial and data science expertise combined
with automation and machine learning to provide
an actuarial automation and decision support for
life and health insurers.
Orbis Diagnostics Ltd Developing point of care diagnostics for use in
pharmacy and other settings.
PowerON Ltd Developing soft robotic components to enable the
development of more lifelike robots.
Sensor Holdings Ltd
(trading as Stretch-
Sense)
Sell motion capture gloves that combine sensors
and machine learning for finger tracking in
animation and gaming.
TasmanIon Ltd Aluminium-ion battery technologies suited for grid
storage and portable applications
Xframe Pty Ltd Selling recoverable, reusable building frames for
sustainable construction.
ZeroJet Ltd Selling electric jet propulsion systems to eliminate
the need for combustion engines on small
watercraft

For more information visit “The BIF Story” at our website.
0% Cash
14% Energy & clean
technologies
37% Life sciences and
medical technologies
19% Information
technology services
30% Materials &
technologies
Portfolio value by sector